GB1286014A - Anti-tumour substance and process for producing the same - Google Patents

Anti-tumour substance and process for producing the same

Info

Publication number
GB1286014A
GB1286014A GB42317/70A GB4231770A GB1286014A GB 1286014 A GB1286014 A GB 1286014A GB 42317/70 A GB42317/70 A GB 42317/70A GB 4231770 A GB4231770 A GB 4231770A GB 1286014 A GB1286014 A GB 1286014A
Authority
GB
United Kingdom
Prior art keywords
extract
product
ion
saturated concentration
saturated
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired
Application number
GB42317/70A
Other languages
English (en)
Inventor
Hajime Okamoto
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Individual
Original Assignee
Individual
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Individual filed Critical Individual
Publication of GB1286014A publication Critical patent/GB1286014A/en
Expired legal-status Critical Current

Links

Classifications

    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K35/00Medicinal preparations containing materials or reaction products thereof with undetermined constitution
    • A61K35/66Microorganisms or materials therefrom
    • A61K35/74Bacteria
    • A61K35/741Probiotics
    • A61K35/744Lactic acid bacteria, e.g. enterococci, pediococci, lactococci, streptococci or leuconostocs
    • YGENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10TECHNICAL SUBJECTS COVERED BY FORMER USPC
    • Y10STECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10S435/00Chemistry: molecular biology and microbiology
    • Y10S435/8215Microorganisms
    • Y10S435/822Microorganisms using bacteria or actinomycetales
    • Y10S435/885Streptococcus
    • YGENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10TECHNICAL SUBJECTS COVERED BY FORMER USPC
    • Y10STECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10S530/00Chemistry: natural resins or derivatives; peptides or proteins; lignins or reaction products thereof
    • Y10S530/82Proteins from microorganisms
    • Y10S530/825Bacteria

Landscapes

  • Life Sciences & Earth Sciences (AREA)
  • Health & Medical Sciences (AREA)
  • Microbiology (AREA)
  • Mycology (AREA)
  • Epidemiology (AREA)
  • Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Molecular Biology (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
  • Preparation Of Compounds By Using Micro-Organisms (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Polysaccharides And Polysaccharide Derivatives (AREA)
GB42317/70A 1969-09-06 1970-09-03 Anti-tumour substance and process for producing the same Expired GB1286014A (en)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
JP44070283A JPS4843841B1 (cg-RX-API-DMAC7.html) 1969-09-06 1969-09-06

Publications (1)

Publication Number Publication Date
GB1286014A true GB1286014A (en) 1972-08-16

Family

ID=13426989

Family Applications (1)

Application Number Title Priority Date Filing Date
GB42317/70A Expired GB1286014A (en) 1969-09-06 1970-09-03 Anti-tumour substance and process for producing the same

Country Status (6)

Country Link
US (1) US3810819A (cg-RX-API-DMAC7.html)
JP (1) JPS4843841B1 (cg-RX-API-DMAC7.html)
CA (1) CA928236A (cg-RX-API-DMAC7.html)
DE (1) DE2043971C3 (cg-RX-API-DMAC7.html)
FR (1) FR2070674B1 (cg-RX-API-DMAC7.html)
GB (1) GB1286014A (cg-RX-API-DMAC7.html)

Families Citing this family (8)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4021541A (en) * 1975-10-20 1977-05-03 New York Medical College Antigen isolated from group A (beta-hemolytic) streptococci and method for isolating the same
PH14773A (en) * 1976-01-01 1981-12-09 Kureha Chemical Ind Co Ltd Protein-bound polysaccharides
JPS5315495A (en) * 1976-07-22 1978-02-13 Kureha Chem Ind Co Ltd Preparation of polysaccharides
DE2652684C3 (de) * 1976-11-19 1982-03-25 Lange, Kurt, New York, N.Y. Wasserlösliches Protein (Antigen) aus β-hämolysierenden Streptokokken der Gruppe A
JPS557014A (en) * 1978-06-29 1980-01-18 Chugai Pharmaceut Co Ltd Antitumor agent and its preparation
JPS55102596A (en) * 1978-12-27 1980-08-05 Meiji Seika Kaisha Ltd Novel antibiotic substance, bn-183b substance, and its preparation
IL73883A (en) * 1984-12-20 1990-12-23 Yeda Res & Dev Monoclonal antibodies against tnf-alpha,hybridomas producing them and method for the purification of tnf-alpha
US6126945A (en) * 1989-10-03 2000-10-03 Pharmacia Ab Tumor killing effects of enterotoxins, superantigens, and related compounds

Also Published As

Publication number Publication date
FR2070674B1 (cg-RX-API-DMAC7.html) 1974-08-30
JPS4843841B1 (cg-RX-API-DMAC7.html) 1973-12-21
CA928236A (en) 1973-06-12
US3810819A (en) 1974-05-14
DE2043971B2 (de) 1978-11-23
FR2070674A1 (cg-RX-API-DMAC7.html) 1971-09-17
DE2043971C3 (de) 1979-07-12
DE2043971A1 (de) 1971-09-30

Similar Documents

Publication Publication Date Title
Pollard Myosin purification and characterization
ES380950A1 (es) Metodo para la preparacion de un nuevo complejo de protrom-bina.
Inesi et al. Trypsin digestion of fragmented sarcoplasmic reticulum
ÖZKINAY et al. A simple trypsin‐Giemsa technique producing simultaneous G‐and C‐banding in human chromosomes
ES8407516A1 (es) Procedimiento para la obtencion de pancreatina
ES8506196A1 (es) Un procedimiento para preparar un extracto completo de organos de mamiferos y de cultivos celulares
GB1286014A (en) Anti-tumour substance and process for producing the same
ES8402942A1 (es) Procedimiento para la produccion de un preparado de tromboplastina de tejidos.
GB1430217A (en) Process for the preparation of an infusible storage-stable haemoglobin solution
Schwertmann et al. Hydrogen-aluminum clays: A third buffer range appearing in potentiometric titration
Chaiet et al. Isolation of a pure dextranase from Penicillium funiculosum
US4334018A (en) Process and reagent for the determination of prothrombin
GB1401737A (en) Anti-coagulant isolation
US3677901A (en) Process for the production of glycerokinase
US3660238A (en) Extraction of asparaginase from bacterial culture
GB1380056A (en) Process for isolating a fibrin-stabilizing factor
GB1060513A (en) Process for the preparation of glucuronoglycosaminoglycan hyaluronate lyase
Cooper et al. The soluble proteins of bovine hide II. Extraction by aqueous sodium phosphate and half-saturated lime
US3652401A (en) Purification of dextranase using iron salts
GB1387592A (en) Process for preparing an interferon inducer
Tishkoff et al. Preparation and properties of human prothrombin complex
SU575353A1 (ru) Способ получени карбоксипептидазы
GB966672A (en) Process for the manufacture of streptokinase
ES8200228A1 (es) Metodo para producir preparados medicinales para el trata- miento de carcinomas
Carlson et al. Studies on the dextransucrase of Leuconostoc dextranicum

Legal Events

Date Code Title Description
PS Patent sealed [section 19, patents act 1949]
PE20 Patent expired after termination of 20 years